C57BL/6JCya-Tgfaem1/Cya
Common Name:
Tgfa-KO
Product ID:
S-KO-16966
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tgfa-KO
Strain ID
KOCMP-21802-Tgfa-B6J-VB
Gene Name
Product ID
S-KO-16966
Gene Alias
wa-1; wa1
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
6
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tgfaem1/Cya mice (Catalog S-KO-16966) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000032066
NCBI RefSeq
NM_031199.5
Target Region
Exon 3
Size of Effective Region
~2.5 kb
Detailed Document
Overview of Gene Research
Tgfa, or transforming growth factor alpha, is a polypeptide growth factor with a high affinity for the epidermal growth factor receptor. It is an essential cell regulator, acting during processes such as cell proliferation, differentiation, migration, and apoptosis [3]. TGFA-related signaling pathways often involve growth factor receptors and their cytoplasmic intermediates, which are crucial in cell-related activities [2].
In cervical cancer, TGFA was highly expressed in cancer tissues and cells. Knockdown of TGFA could inhibit the proliferation, migration, and invasion of cervical cancer cells, and its knockout led to a significant reduction in the expression of IL family and MMP family proteins in CESC cell lines, suggesting its role in promoting cervical cancer development [1]. In osteosarcoma, cisplatin inhibited the proliferation of Saos-2 cells by upregulating miR-376c and downregulating TGFA expression [4]. Also, in non-syndromic cleft lip and palate, the TGFA gene polymorphism rs11466297 showed a significant association and acted as a risk factor in the Indian population [5].
In conclusion, Tgfa is a significant cell regulator involved in multiple biological processes. Studies using gene knockdown or knockout models have revealed its role in promoting the development of certain cancers like cervical and osteosarcoma, and its association with non-syndromic cleft lip and palate. These findings contribute to understanding the disease mechanisms and potentially identifying new treatment targets.
References:
1. Ma, Xiaoxuan, Zheng, Jingying, He, Kang, Zhao, Lijing, Wang, Lisheng. 2023. TGFA expression is associated with poor prognosis and promotes the development of cervical cancer. In Journal of cellular and molecular medicine, 28, e18086. doi:10.1111/jcmm.18086. https://pubmed.ncbi.nlm.nih.gov/38152044/
2. Garcia-Lezana, Teresa, Lopez-Canovas, Juan Luis, Villanueva, Augusto. 2020. Signaling pathways in hepatocellular carcinoma. In Advances in cancer research, 149, 63-101. doi:10.1016/bs.acr.2020.10.002. https://pubmed.ncbi.nlm.nih.gov/33579428/
3. Bezamat, Mariana, Souza, Juliana F, Silva, Fernanda M F, Modesto, Adriana, Vieira, Alexandre R. 2021. Gene-environment interaction in molar-incisor hypomineralization. In PloS one, 16, e0241898. doi:10.1371/journal.pone.0241898. https://pubmed.ncbi.nlm.nih.gov/33406080/
4. Wang, Yuan, Wu, Yichao, Cai, Awei, Xu, Tangbing, Hu, Yong. 2021. Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway. In Bosnian journal of basic medical sciences, 21, 163-173. doi:10.17305/bjbms.2020.4485. https://pubmed.ncbi.nlm.nih.gov/32020849/
5. Avasthi, Kapil Kumar, Agarwal, Amit, Agarwal, Sarita. . Association of MTHFR, BMP4, TGFA and IRF6 Polymorphisms with Non-Syndromic Cleft lip and Palate in North Indian Patients. In Avicenna journal of medical biotechnology, 14, 175-180. doi:10.18502/ajmb.v14i2.8879. https://pubmed.ncbi.nlm.nih.gov/35633991/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen